![PDF) Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study PDF) Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study](https://i1.rgstatic.net/publication/355235647_Intratympanic_Administration_of_OTO-313_Reduces_Tinnitus_in_Patients_With_Moderate_to_Severe_Persistent_Tinnitus_A_Phase_12_Study/links/6194002b3068c54fa5f14d32/largepreview.png)
PDF) Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study
Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study
![SY Investing on X: "$OTIC (+15% PM) Otonomy reported positive topline data data from the Phase 1/2 trial of OTO-313 in patients with tinnitus. 43% of OTO-313 patients were responders at both SY Investing on X: "$OTIC (+15% PM) Otonomy reported positive topline data data from the Phase 1/2 trial of OTO-313 in patients with tinnitus. 43% of OTO-313 patients were responders at both](https://pbs.twimg.com/media/EcUKvlLUYAEBFeM.jpg)
SY Investing on X: "$OTIC (+15% PM) Otonomy reported positive topline data data from the Phase 1/2 trial of OTO-313 in patients with tinnitus. 43% of OTO-313 patients were responders at both
![Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus A Phase 1/2 Study : r/longevity Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus A Phase 1/2 Study : r/longevity](https://external-preview.redd.it/Esr6iP63oB14H6Z9KGyaMDrZEMof2aTHqV-ahZMnjn8.jpg?auto=webp&s=bc023bbb38c3a6ba47823016084a4265b32835ee)
Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus A Phase 1/2 Study : r/longevity
![Otonomy Now Recruiting Participants for Phase 2 Study of OTO-313 in Tinnitus [Update: New Locations Added] - Tinnitus Treatment Report Otonomy Now Recruiting Participants for Phase 2 Study of OTO-313 in Tinnitus [Update: New Locations Added] - Tinnitus Treatment Report](https://www.tinnitustreatmentreport.com/wp-content/uploads/oto-313-phase-2-article.png)
Otonomy Now Recruiting Participants for Phase 2 Study of OTO-313 in Tinnitus [Update: New Locations Added] - Tinnitus Treatment Report
OTO-313 is a new pharmaceutical research drug aimed at finding a cure for tinnitus. Know more about the latest update about this new research drug! Watch the video here: https://bit.ly/PTACFT21 | OTO-313
![SY Investing on X: "$OTIC (+15% PM) Otonomy reported positive topline data data from the Phase 1/2 trial of OTO-313 in patients with tinnitus. 43% of OTO-313 patients were responders at both SY Investing on X: "$OTIC (+15% PM) Otonomy reported positive topline data data from the Phase 1/2 trial of OTO-313 in patients with tinnitus. 43% of OTO-313 patients were responders at both](https://pbs.twimg.com/media/EcUKvlTU8AArlaC.jpg)
SY Investing on X: "$OTIC (+15% PM) Otonomy reported positive topline data data from the Phase 1/2 trial of OTO-313 in patients with tinnitus. 43% of OTO-313 patients were responders at both
![BREAKING: Otonomy Completes Phase 2 Clinical Trial of OTO-313 for Tinnitus... - Tinnitus Treatment Report BREAKING: Otonomy Completes Phase 2 Clinical Trial of OTO-313 for Tinnitus... - Tinnitus Treatment Report](https://www.tinnitustreatmentreport.com/wp-content/uploads/oto-313-phase-2-completed-july-2022.png)